Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Names New CEO; Affy Adds Director; Transgenomic Loses Director; Codon Hires CFO; and Others

NEW YORK (GenomeWeb News) – Gene Logic this week named Charles Dimmler its new CEO. Dimmler replaces Mark Gessler, who will maintain his position as chairman of the board of directors.
 
Dimmler has been on Gene Logic’s board of directors for 10 years, and has involved in biotechnology management and finance for 20.

Affymetrix has named Robert Wayman to its board of directors.
 
Wayman recently retired as executive vice president and CFO at Hewlett-Packard. He had also been a director at HP, Conway, and Sybase.

 
Parag Saxena resigned last week as a director of Transgenomic, the company said this week. Saxena also resigned from his duties on the company’s board-compensation and audit committees.

 
Codon Devices has appointed Daniel Geffken to the post of chief financial officer, the company said this week.
Geffken most recently was executive vice president and CFO at Konarka Technologies.

He has also served as CFO and having held positions involving fundraising, investor relations, and management at Transkaryotic Therapies, CytoTherapeutics, and Omnisonics Medical Technologies.


 
C. Robert Eaton has resigned from his post as president of MdBio, a non-profit group that promotes the growth of the bioscience industry in Maryland, MdBio said this week.
 
Julie Coons, CEO of the Tech Council of Maryland, will take Eaton’s place until a replacement is found.
 
Eaton, who worked for the organization for 10 years, will leave his job at the end of the month to “pursue opportunities in the private sector,” MdBio said.

 
The Burnham Institute for Medical Research has named Robert Zaugg vice president of business development, the institute said this week.
 
The La Jolla, Calif.-based non-profit operates three centers studying cancer, neurosciences, aging, infection, and inflammatory diseases.   
 
Zaugg has worked as an executive, consultant, or scientist at companies including DermAegis, GTS Proteomics, Triton Biosciences, Vical, and Teknekron.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.